RXDX Overview
Upcoming Projects (RXDX)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (RXDX)
-
Investigating Loxo’s larotrectinib in treating TRK cancers with upcoming data in Q4
Tickers: LOXO, EXEL, RXDX, NVS
Execute By: Dec 12, 2017
Upcoming & Overdue Catalysts (RXDX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (RXDX)
-
Ignyta (RXDX) Presents Phase 1 Data Evaluating Entrectinib in Patients with TRK-, ROS1- or ALK-Positive Solid Tumors
Ticker: RXDX
Occurred on: Feb 09, 2017
Strategic Initiatives (RXDX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
